col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer-Verlag: Journal of Neuroimmune Pharmacology
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―09 Racial Health Disparity and COVID-19 Santosh Kumar, Prashant Kumar, Sunitha Kodidela, Benjamin Duhart, Alina Cernasev, Anantha Nookala, et al. (+3)
2 [GO] 2021―Aug―24 Investigating Neurological Manifestations of SARS-CoV-2 Maryam Mozafar, Seyed Amir Mirmotalebisohi, Marzieh Sameni, Hakimeh Zali
3 [GO] 2021―Jun―28 Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop Santosh Kumar, Gurudutt Pendyala, Sowmya V. Yelamanchili, Pankaj Seth, Sanjay Maggirwar, Jean M. Bidlack, Sulie L. Chang
4 [GO] 2021―May―28 The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections Kevin Roe
5 [GO] 2021―May―18 Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals Marco Cosentino, Marco Ferrari, Franca Marino
6 [GO] 2021―Feb―05 A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Jacob D. Cohen, et al. (+21)
7 [GO] 2021―Feb―03 Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation? Adriano José Maia Chaves Filho, Franciane Gonçalves, Melina Mottin, Carolina Horta Andrade, Silvia Nunes Szente Fonseca, Danielle S. Macedo
8 [GO] 2021―Jan―18 Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome Júlia Leão Batista Simões, Margarete Dulce Bagatini
9 [GO] 2021―Jan―11 ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy Ramesh K. Paidi, Malabendu Jana, Rama K. Mishra, Debashis Dutta, Sumita Raha, Kalipada Pahan
10 [GO] 2021―Jan―06 Is COVID-19 Gender-sensitive? Shreya Mukherjee, Kalipada Pahan
11 [GO] 2021―Jan―06 Pharmacotherapeutics of SARS-CoV-2 Infections Bhavesh D. Kevadiya, Jatin Machhi, Jonathan Herskovitz, Maxim D. Oleynikov, Wilson R. Blomberg, Neha Bajwa, et al. (+14)
12 [GO] 2021―Jan―06 SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation Jessica. L. Reynolds, Supriya D. Mahajan
13 [GO] 2021―Jan―04 Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? Francesco Benedetti, Mario Gennaro Mazza, Giulio Cavalli, Fabio Ciceri, Lorenzo Dagna, Patrizia Rovere-Querini
14 [GO] 2020―Oct―26 Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? Francesco Benedetti, Mario Mazza, Giulio Cavalli, Fabio Ciceri, Lorenzo Dagna, Patrizia Rovere-Querini
15 [GO] 2020―Sep―15 Infectivity of SARS-CoV-2: there Is Something More than D614G? Saathvik R. Kannan, Austin N. Spratt, Thomas P. Quinn, Xiao Heng, Christian L. Lorson, Anders Sönnerborg, et al. (+2)
16 [GO] 2020―Sep―10 Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review Tejas K. Patel, Manish Barvaliya, Bhavesh D. Kevadiya, Parvati B. Patel, Hira Lal Bhalla
17 [GO] 2020―Sep―10 Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review Tejas K. Patel, Manish Barvaliya, Bhavesh D. Kevadiya, Parvati B. Patel, Hira Lal Bhalla
18 [GO] 2020―Jul―21 The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections Jatin Machhi, Jonathan Herskovitz, Ahmed M. Senan, Debashis Dutta, Barnali Nath, Maxim D. Oleynikov, et al. (+9)
19 [GO] 2020―Jun―29 Clomipramine Could Be Useful in Preventing Neurological Complications of SARS-CoV-2 Infection B. Nobile, M. Durand, E. Olié, S. Guillaume, J. P. Molès, E. Haffen, P. Courtet
20 [GO] 2020―Jun―25 Comment on “Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?” Erkan Cure, Medine Cumhur Cure, Adem Kucuk
21 [GO] 2020―Jun―11 May the Central Nervous System Be Fogged by the Cytokine Storm in COVID-19?: an Appraisal Yasin Hasan Balcioglu, Umit Haluk Yesilkaya, Hasan Gokcay, Simge Seren Kirlioglu
22 [GO] 2020―May―23 SARS-CoV-2 Infection Leads to Neurological Dysfunction Arpan Acharya, Bhavesh D. Kevadiya, Howard E. Gendelman, Siddappa N. Byrareddy
23 [GO] 2020―May―15 Smooth or Risky Revisit of an Old Malaria Drug for COVID-19? Priyanka Pahan, Kalipada Pahan
24 [GO] 2020―May―07 Feasibility of Therapeutic Effects of the Cholinergic Anti-Inflammatory Pathway on COVID-19 Symptoms Roham Mazloom


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.006 sec